Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' BIOTON S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by BIOTON S.A. since January 2007.
– Provides intelligence on BIOTON S.A.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by BIOTON S.A. and its subsidiaries since 2007. – Information about key financial and legal advisors for BIOTON S.A.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes BIOTON S.A.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by BIOTON S.A.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about BIOTON S.A.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Neuca SA (NEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...
Summary Bioton SA (Bioton) manufactures medicines and pharmaceutical preparations and produces pharmaceutical substances.Its product portfolio includes antibiotics; anesthetic drugs and eye drops; recombinant human insulin in different forms; human growth hormone and orally taken anti-diabetic medicines. The company’s...
Summary Neuca SA (Neuca) is a provider of pharmaceutical and medical development solutions.The company offers wholesale of pharmaceuticals and medical equipment to pharmacies and hospitals. Its services comprise private brand management, logistics and distribution, telemarketing, and education and training.Neuca...
74 pages •
By Wright Investors' Service
• Sep 2018
A textual analysis of the financial results for Biomed Lublin Wytwornia Surowic I Szczepionek SA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the...
Polpharma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report...
69 pages •
By Wright Investors' Service
• Aug 2018
A textual analysis of the financial results for Bioton SA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information,...